Factors Influencing the Adoption of User-Administered Injectable Contraceptives in the United States
January 9, 2026
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Draximage Gluceptate
Synonyms :
technetium Tc-99m gluceptate
Class :
Radiopharmaceutical
Brand Name :
Draximage Gluceptate
Synonyms :
technetium Tc-99m gluceptate
Class :
Radiopharmaceutical
Dosage Forms & Strengths
Kit, Intravenous
25 mg/vial
Dose of 0.03 mL/kg intravenously administered 10 to 30 minutes before 15 to 25 mCi of sodium pertechnetate Tc 99m
Administer dose of 15 to 20 mCi intravenously
not determined
Refer to adult dosing
Actions and Spectrum
The uptake of technectium Tc-99m gluceptate by the kidneys allows for the visualization and assessment of renal function and blood flow. The radioactive decay of Tc-99m results in the emission of gamma rays.
Frequency defined
<1%
Erythema
Dyspnea
Skin rash
Vomiting
Allergic dermatitis
Nausea
Flushing
Hypersensitivity
Pruritus
Black Box Warning
None
Contraindication/Caution:
Contraindication:
None
Caution:
Pregnancy consideration:
Pregnancy category: N/A
Lactation: technetium Tc 99m is excreted into human breast milk
Pregnancy Categories:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology
technetium Tc-99m gluceptate acts as a chelating agent that binds to Tc-99m, forming a stable complex.
The Tc-99m gluceptate complex is then preferentially taken up by the kidneys, where it is filtered by the glomeruli and excreted into the renal tubules.
Pharmacodynamics
technectium Tc-99m gluceptate complex emits gamma radiation as Tc-99m undergoes radioactive decay.
The emitted gamma rays are used to create images that depict the distribution of the radiopharmaceutical in the body.
Pharmacokinetics
Absorption
technetium Tc-99m gluceptate is rapidly enters the bloodstream after intravenous administration.
Distribution
technectium Tc-99m gluceptate circulates throughout the body.
Metabolism
technetium Tc-99m gluceptate is not significantly metabolized in the body.
Elimination and excretion
technectium Tc-99m gluceptate is primarily eliminated from the body through the urinary system.
Administration
technetium Tc-99m gluceptate is typically administered intravenously as an injection into the bloodstream.
Patient information leaflet
Generic Name: technetium Tc-99m gluceptate
Why do we use technetium Tc-99m gluceptate?
technetium Tc-99m gluceptate used as brain imaging agent for evaluation of brain perfusion.
technetium Tc-99m gluceptate used as kidney imaging agent for evaluation of renal perfusion.
technetium Tc-99m gluceptate used as cardiac blood pool imaging agent.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
